High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers

European Journal of Surgical Oncology

Volumn 38, Issue 6, 2012, Pages 523-530

  Hou, X ^a   Li, Y ^a   Luo, R Z ^a   Fu, J H ^a   He, J H ^a   Zhang, L J ^a   Yang, H X ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Non small cell lung cancer; p300; Prognosis; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEIN P300;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENCE RISK; RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME; TISSUE MICROARRAY; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; E1A-ASSOCIATED P300 PROTEIN; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PLATINUM COMPOUNDS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTEIN ARRAY ANALYSIS; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84862822518     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2012.02.180     Document Type: Article

References (30)

1. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108 (Pubitemid 40372904)
2. A. Jemal, M.J. Thun, and L.A. Ries Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control J Natl Cancer Inst 100 2008 1672 1694
3. W.D. Travis, L.B. Travis, and S.S. Devesa Lung cancer Cancer 75 1995 191 202
4. M. Guermah, V.B. Palhan, A.J. Tackett, B.T. Chait, and R.G. Roeder Synergistic functions of SII and p300 in productive activator-dependent transcription of chromatin templates Cell 125 2006 275 286
5. A.S. Turnell, and J.S. Mymryk Roles for the coactivators CBP and p300 and the APC/C E3 ubiquitin ligase in E1A-dependent cell transformation Br J Cancer 95 2006 555 560 (Pubitemid 44325894)
6. J.S. Byun, M.M. Wong, and W. Cui Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexes Proc Natl Acad Sci USA 106 2009 19286 19291
7. N. Koshiishi, J.M. Chong, and T. Fukasawa p300 gene alterations in intestinal and diffuse types of gastric carcinoma Gastric Cancer 7 2004 85 90 (Pubitemid 38899658)
8. S.A. Gayther, S.J. Batley, and L. Linger Mutations truncating the EP300 acetylase in human cancers Nat Genet 24 2000 300 303 (Pubitemid 30132203)
9. S. Fan, Y.X. Ma, and C. Wang p300 Modulates the BRCA1 inhibition of estrogen receptor activity Cancer Res 62 2002 141 151 (Pubitemid 34073998)
10. D. Bandyopadhyay, N.A. Okan, E. Bales, L. Nascimento, and P.A. Cole Medrano EE.Down-regulation of p300/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes Cancer Res 62 2002 6231 6239 (Pubitemid 35244476)
11. M.V. Karamouzis, P.A. Konstantinopoulos, and A.G. Papavassiliou Roles of CREB-binding protein (CBP)/p300 in respiratory epithelium tumorigenesis Cell Res 17 2007 324 332 (Pubitemid 46639937)
12. C. Zhang, K. Li, and L. Wei p300 expression repression by hypermethylation associated with tumour invasion and metastasis in oesophageal squamous cell carcinoma J Clin Pathol 60 2007 1249 1253 (Pubitemid 350084547)
13. A.R. Green, C. Burney, and C.J. Granger The prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor NCOR2/SMRT is an independent indicator of poor outcome Breast Cancer Res Treat 110 2008 427 437 (Pubitemid 351962584)
14. J.D. Debes, T.J. Sebo, C.M. Lohse, L.M. Murphy, D.A. Haugen, and D.J. Tindall p300 in prostate cancer proliferation and progression Cancer Res 63 2003 7638 7640 (Pubitemid 37466688)
15. M. Li, R.Z. Luo, and J.W. Chen High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinoma J Transl Med 9 2011 5
16. R. Rami-Porta, C. Wittekind, and P. Goldstraw Complete resection in lung cancer surgery: proposed definition Lung Cancer 49 2005 25 33 (Pubitemid 40798090)
17. O. Lababede, M. Meziane, and T. Rice Seventh edition of the cancer staging manual and stage grouping of lung cancer: quick reference chart and diagrams Chest 139 2011 183 189
18. N. Martini, and M.R. Melamed Multiple primary lung cancers J Thorac Cardiovasc Surg 70 1975 606 612
19. Z.H. Zhu, B.Y. Sun, and Y. Ma Three immunomarker support vector machines-based prognostic classifiers for stage IB non-small-cell lung cancer J Clin Oncol 27 2009 1091 1099
20. M.E. Fermento, N.A. Gandini, and C.A. Lang Intracellular distribution of p300 and its differential recruitment to aggresomes in breast cancer Exp Mol Pathol 88 2010 256 264
21. R.H. Goodman, and S. Smolik CBP/p300 in cell growth, transformation, and development Genes Dev 14 2000 1553 1577 (Pubitemid 30460905)
22. A. Magenta, C. Cenciarelli, and F. De Santa MyoD stimulates RB promoter activity via the CREB/p300 nuclear transduction pathway Mol Cell Biol 23 2003 2893 2906 (Pubitemid 36403086)
23. M. Wasner, K. Tschop, and K. Spiesbach Cyclin B1 transcription is enhanced by the p300 coactivator and regulated during the cell cycle by a CHR-dependent repression mechanism FEBS Lett 536 2003 66 70 (Pubitemid 36206408)
24. S. Takeuchi, C.R. Bartram, and M. Wada Allelotype analysis of childhood acute lymphoblastic leukemia Cancer Res 55 1995 5377 5382
25. K. Shigeno, H. Yoshida, and L. Pan Disease-related potential of mutations in transcriptional cofactors CREB-binding protein and p300 in leukemias Cancer Lett 213 2004 11 20 (Pubitemid 39118529)
26. M.R. Garbati, G. Alco, and T.D. Gilmore Histone acetyltransferase p300 is a coactivator for transcription factor REL and is C-terminally truncated in the human diffuse large B-cell lymphoma cell line RC-K8 Cancer Lett 291 2010 237 245
27. J. Qi, K. Nakayama, and R.D. Cardiff Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors Cancer Cell 18 2010 23 38
28. J. Pouyssegur, F. Dayan, and N.M. Mazure Hypoxia signalling in cancer and approaches to enforce tumour regression Nature 441 2006 437 443 (Pubitemid 44050138)
29. J.P. Pignon, H. Tribodet, and G.V. Scagliotti Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group J Clin Oncol 26 2008 3552 3559
30. S. Burdett, A. Stewart, and L. Rydzewska A systematic review and meta-analysis of the literature: chemotherapy and surgery versus surgery alone in non-small cell lung cancer J Thorac Oncol 1 2006 611 621 (Pubitemid 47163946)